| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67cc6c3aded41f52d3986b2fcde2da7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9fcb8cecbef06dc47cf1cbce0bd235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c430978d48c2a76c496ac7454144b119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_962dbb053474e287e91d00881f701554 |
| publicationDate |
2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021150188-A1 |
| titleOfInvention |
Crystalline form c of vortioxetine hydrobromide |
| abstract |
The present invention relates to crystalline form C of vortioxetine hydrobromide for use in the treatment of major depressive disorder (MDD). Furthermore, the invention provides a composition comprising crystalline form C of vortioxetine hydrobromide and processes for the preparation of compositions comprising the form C. |
| priorityDate |
2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |